GSTM3 Function and Polymorphism in Cancer: Emerging but Promising

Shunda Wang1, Jinshou Yang1, Lei You1

  • 1Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Insights

Glutathione S-transferases mu3 (GSTM3) plays a key role in cancer development, influencing tumor progression and chemoresistance. Understanding GSTM3's function is crucial for improving cancer prevention and targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer remains a leading cause of mortality, with incomplete understanding of its molecular drivers.
  • Glutathione S-transferases mu3 (GSTM3) is a phase II enzyme involved in detoxifying xenobiotics and metabolizing electrophilic substances.
  • GSTM3 exhibits polymorphisms and influences tumorigenesis, invasion, metastasis, chemoresistance, and oxidative stress in various cancers.

Purpose of the Study:

  • To provide a comprehensive overview of GSTM3.
  • To elucidate the role of GSTM3 in cancer development and progression.
  • To highlight the potential of GSTM3 as a biomarker and therapeutic target.

Main Methods:

  • Literature review and synthesis of existing research on GSTM3.
  • Analysis of GSTM3's involvement in carcinogen metabolism and detoxification pathways.
  • Examination of GSTM3's regulatory functions in cellular processes relevant to cancer.

Main Results:

  • GSTM3 polymorphisms are linked to differential cancer susceptibility and progression.
  • GSTM3 modulates key cancer hallmarks including invasion, metastasis, and chemoresistance.
  • GSTM3 is implicated in regulating reactive oxygen species (ROS) and oxidative stress-mediated pathology.

Conclusions:

  • GSTM3 is a significant factor in cancer biology, affecting multiple aspects of tumor progression.
  • Further research into GSTM3 regulatory mechanisms and functions can advance cancer prevention strategies.
  • Targeting GSTM3 or understanding its interactions may offer novel avenues for cancer therapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K